IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,937 | -38.4% | 37,241 | +1.4% | 0.00% | 0.0% |
Q2 2023 | $102,096 | +61.2% | 36,725 | +5.5% | 0.00% | 0.0% |
Q1 2023 | $63,331 | -63.1% | 34,797 | +2.7% | 0.00% | -50.0% |
Q4 2022 | $171,807 | +6.7% | 33,887 | +4.5% | 0.00% | 0.0% |
Q3 2022 | $161,000 | +34.2% | 32,443 | +0.3% | 0.00% | +100.0% |
Q2 2022 | $120,000 | -0.8% | 32,341 | +50.5% | 0.00% | 0.0% |
Q1 2022 | $121,000 | -5.5% | 21,495 | +2.1% | 0.00% | 0.0% |
Q4 2021 | $128,000 | -37.3% | 21,056 | +0.7% | 0.00% | -50.0% |
Q3 2021 | $204,000 | +37.8% | 20,915 | +101.7% | 0.00% | +100.0% |
Q2 2021 | $148,000 | -34.2% | 10,370 | +9.4% | 0.00% | -50.0% |
Q1 2021 | $225,000 | – | 9,483 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |